Anastassios Karistinos, M.D., is an Assistant Professor in the Department of Orthopedic Surgery at Baylor College of Medicine. He holds clinical roles at Ben Taub Hospital, Baylor Clinic, and the Michael E. DeBakey VA Medical Center in Houston, Texas. Dr. Karistinos completed his medical degree (MD) at Aristotle University of Thessaloniki (1993), followed by residency at Louisiana State University Health Sciences Center (2005) and a fellowship in Advanced Orthopaedics and Sports Medicine (2005). His professional interests focus on complex musculoskeletal conditions including multi-ligament knee injuries, meniscal transplantation, cartilage restoration techniques (OATS, ACI), knee osteotomies, shoulder instability, rotator cuff injuries, and shoulder arthroplasty. He emphasizes patient safety and critical evaluation of emerging medical technologies, prioritizing evidence-based treatments. Dr. Karistinos is certified by the American Board of Orthopaedic Surgery in both Orthopaedic Surgery and Orthopaedic Sports Medicine. He is a Fellow of the American Academy of Orthopaedic Surgeons and specializes in sports medicine, arthroscopic surgery, and trauma care. His research integrates anatomical insights with clinical outcomes to improve surgical techniques and patient recovery processes.
Mohamed Bouri is a Senior Lecturer and Researcher at École Polytechnique Fédérale de Lausanne (EPFL), where he is affiliated with the School of Engineering (STI) and specifically the Microengineering Department (SCI-STI-MB). He is part of the ReHAssist research group (http://rehassist.epfl.ch), which focuses on rehabilitation robotics and human-robot interaction. His office is located in the MED Building (MED 3 1016) at Station 9, 1015 Lausanne. Dr. Bouri's research spans several key areas in robotics and rehabilitation engineering. His primary focus is on the development and control of exoskeleton systems for mobility assistance and rehabilitation. He has made significant contributions to hip exoskeleton technology, adaptive control strategies, and human-robot interaction paradigms. His work bridges engineering principles with clinical applications, particularly for individuals with mobility impairments and neurological conditions. Additional research interests include sensory substitution techniques, balance control systems, and astronomical instrumentation involving robotic fiber positioners for multi-object spectrographs. Analysis of Dr. Bouri's recent publications reveals a strong emphasis on practical applications of robotics in rehabilitation settings. His work increasingly focuses on user-centered design, adaptive control systems that respond to individual user needs, and ecological validity in testing environments. There's a clear trend toward developing systems that can function effectively in real-world scenarios rather than controlled laboratory settings. His research also shows growing integration of physiological feedback mechanisms and multimodal sensing to enhance human-robot cooperation, with applications spanning from Parkinson's disease rehabilitation to astronomical instrumentation. Dr. Bouri has supervised numerous doctoral students whose theses reflect the breadth of his research interests, including work on lower-limb exoskeletons, robotic control systems, and rehabilitation technologies. His collaborative approach is evident in the extensive list of co-authored publications across multiple institutions and disciplines, demonstrating his ability to bridge engineering with clinical and astronomical applications. Based at EPFL's Microengineering Department, Dr. Bouri leads research activities within the ReHAssist laboratory, which specializes in rehabilitation assistance technologies. The lab focuses on developing innovative robotic solutions for mobility assistance, with particular expertise in exoskeleton design, control algorithms, and human-robot interaction paradigms. His work on projects like TWIICE One has demonstrated real-world impact in assistive technology development.
Christopher E. Nelson is an Assistant Professor in the Department of Biomedical Engineering at the University of Arkansas, College of Engineering. His lab focuses on developing biologically inspired strategies for controlled drug and gene delivery, particularly in the context of gene therapy and regenerative medicine. He is actively supported by the NIH, DoD, and Arkansas Bioscience Institute. Education: Postdoctoral Fellow – Duke University Ph.D. – Vanderbilt University B.S. – University of Arkansas Research Focus: Dr. Nelson’s lab integrates genome editing technologies with targeted delivery systems to address challenges in treating genetic diseases and promoting tissue regeneration. Major themes include CRISPR/Cas9 delivery , gene regulation in wound healing , and safe-harbor genome integration in skeletal muscle. His work spans viral and non-viral delivery vehicles , including lipid nanoparticles and AAV vectors, with a strong emphasis on preclinical validation in models of Duchenne muscular dystrophy and inflammatory disease. Scientific Awards: Controlled Release Society Postdoctoral Fellowship The Hartwell Foundation Postdoctoral Fellowship NIH Pathway to Independence Award (K99/R00) Funding & Support: The Nelson Lab is currently funded by: NIH NIGMS R35 DoD CDMRP DMD IDEA Award Arkansas Bioscience Institute University of Arkansas Engineering & Honors Colleges Lab & Team: The Nelson Lab is a dynamic, interdisciplinary team working at the intersection of gene editing, biomaterials, and regenerative medicine. They regularly present at national conferences such as ASGCT and NCUR, and mentor undergraduate researchers through SURF and Honors College grants.
Dr. Bill Sheel is a Professor and Distinguished University Scholar at the School of Kinesiology, University of British Columbia. His research focuses on the integrative physiology of exercise, particularly respiratory and cardiovascular interactions. Email: bill.sheel@ubc.ca Office: Chan Gunn Pavilion, Room 221B, Vancouver, BC Lab: Health and Integrative Physiology Laboratory Research Interests: Dr. Sheel investigates respiratory physiology during exercise, cardiovascular modulation by breathing patterns, and human performance optimization. His work spans elite athletes, aging populations, and clinical applications. Publication Trends: Recent studies include pulmonary mechanics in exercise physiology, respiratory muscle training applications, and socio-cultural factors in sports science. Collaborative works address aging interventions and environmental influences on athletic performance. Scientific Recognition: Distinguished University Scholar, UBC Laboratory & Collaborations: Leads the Health and Integrative Physiology Laboratory at UBC, focusing on respiratory-cardiovascular integration and exercise tolerance mechanisms.
Konstantinos Kalogeropoulos is an Assistant Professor at the Department of Biotechnology and Biomedicine, Technical University of Denmark (DTU), leading research at the Cell Diversity Lab. His work bridges proteomics, computational biology, and snake venom research. Current projects: "The Proteomic Landscape during Influenza Infection" (2022-2025) Supervisor for PhD projects on protease network rewiring in psoriasis and wound exudate degradomics Research interests include: Proteomic analysis of inflammatory diseases Snake venom toxin structure prediction Extracellular matrix biomechanics De novo peptide sequencing algorithms Computational modeling of protease networks Recent article trends demonstrate his work in • Database-free proteomics (InstaNovo/InstaNexus) • Snake venom pathophysiology (V-ToCs clustering) • Inflammatory disease biomarkers (psoriasis, impaired healing) • Extracellular matrix mechanics (fibronectin tension, gut inflammation) Advising: Supervises PhD students Polhaus, C. J. M. and Haack, A. M., focusing on protease networks and wound healing.
Suradip Das is a Research Assistant Professor in the Department of Neurosurgery at the Perelman School of Medicine, University of Pennsylvania, where he serves as a Senior Research Investigator. His work bridges neural engineering and regenerative medicine to address critical challenges in nerve and muscle repair. His academic training includes: B.Tech in Biotechnology from Heritage Institute of Technology (2010) PhD in Biosciences and Bioengineering from Indian Institute of Technology Guwahati (2016) Dr. Das specializes in biomaterials development , peripheral nerve injury models , neuromuscular interface engineering , and stem cell-based regeneration . His research pioneers innervated tissue-engineered muscle constructs, demonstrating how motor neurons and endothelial cells synergistically enhance skeletal myocyte maturation. He innovates custom mechanobioreactors that apply tensile forces to guide nanofiber alignment for optimal myofiber formation, significantly advancing volumetric muscle loss treatments. Analysis of his 15 most recent publications reveals a dominant focus on neuromuscular regeneration (75% of articles), with emerging exploration of psychedelic compounds in neural repair. His work consistently integrates human iPSC-derived models , multi-cellular co-cultures , and large-animal validation to address translational gaps. Key trends include optogenetic control of motor units (2023), porcine nerve injury models (2020), and the critical role of pre-innervation in creating pro-regenerative microenvironments (2020-2022). As a core member of the Cullen Lab, Dr. Das collaborates on developing biofabricated neural microtissues for delayed nerve fusion and rapid functional recovery. His research directly informs clinical strategies for peripheral nerve repair and muscle regeneration through rigorous mechanistic studies and innovative engineering solutions.
Dr. Ian Wilson is a researcher at Newcastle University with a focus on medical genetics, nephrology, and genomic analysis. His work spans genetic determinants of kidney diseases, mitochondrial disorders, and biomarker development. Notable contributions include studies on uromodulin genetics in African populations, copy-number variations in rare diseases, and kidney ciliopathies. He has collaborated extensively on projects involving genome sequencing, mitochondrial replacement therapy, and muscular dystrophy biomarkers. Wilson's research integrates computational tools like machine learning for predictive modeling in urolithiasis and employs advanced imaging techniques for disease progression monitoring. Key areas: Genetic epidemiology, renal genomics, mitochondrial DNA analysis Focus on translational applications: Biomarker development for kidney stones and muscular dystrophies Interdisciplinary collaborations in ophthalmology and orthopedics His publications reflect a commitment to advancing diagnostic accuracy and understanding complex genetic disorders through multi-omics approaches.
Christian P Petersen, PhD is a Professor in the Department of Cell and Developmental Biology at the Weinberg College of Arts and Sciences , Northwestern University Feinberg School of Medicine. His research focuses on molecular mechanisms underlying regeneration in planarians and other organisms. PhD: MIT (2006) Research Interests: Planarian regeneration and tissue patterning Wnt signaling pathway regulation Stem cell biology in regenerative contexts Neurogenesis and injury response Molecular mechanisms of tissue repair Affiliations: Center for Reproductive Science Robert H. Lurie Comprehensive Cancer Center
Theresa Raimondo is the Manning Assistant Professor of Engineering at Brown University, with a secondary appointment in the Division of Biology and Medicine. She joined the Brown Engineering faculty in January 2024 after completing her postdoctoral training at MIT's Koch Institute. Dr. Raimondo leads the Raimondo Research Lab, which focuses on chemically modifying RNA and designing nanoparticles for therapeutic delivery to the body, an immunotherapy concept that holds immense promise in the field of immunoengineering. Her educational background includes: PhD in Engineering Sciences – Bioengineering from Harvard University (2019) MEng from Harvard University (2019) Sc.B. in Chemical and Biochemical Engineering from Brown University (2011) Dr. Raimondo's research is broadly focused on the design of targeted drug-delivery vectors and novel RNA-based therapeutics for applications in cancer, immunotherapy, and tissue regeneration. Her work primarily centers on developing novel lipid nanoparticles (LNPs) for RNA-based therapies, contributing to adjuvanted mRNA-based vaccines and siRNA-based cancer immunotherapies. By optimizing LNP formulation and modulating RNA constructs, she seeks to understand how RNA-LNPs modulate immunity and develop new therapeutic approaches. Her expertise spans biomaterials, drug delivery, biomolecular engineering, nanomedicine, tissue engineering, and regenerative medicine. Analysis of Dr. Raimondo's recent publications reveals a strong focus on RNA delivery systems and lipid nanoparticle technology. Her work spans from fundamental studies on nanoparticle design to applications in cancer immunotherapy, vaccine development, and tissue regeneration. A significant portion of her research involves optimizing lipid formulations for improved mRNA delivery and exploring how these systems interact with the immune system. Her publications demonstrate a trajectory from basic biomaterials research to increasingly translational work with therapeutic applications. Dr. Raimondo has received numerous prestigious awards: 2025 NAE Symposium selection (Grainger Foundation Frontiers of Engineering) 2025 appointment to the inaugural Early Career Board of ACS Applied Bio Materials 2024 selection as MIT Faculty Founder Initiative finalist 2022 Convergence Scholar fellowship from MIT's Marble Center for Cancer Nanomedicine National Science Foundation graduate research fellowship Harvard's Smith family graduate fellowship Dr. Raimondo is actively involved in mentoring students through courses including ENGN 0931L - Biomedical Engineering Design and Innovation II, ENGN 1490 - Biomaterials, and ENGN 1931L - Biomedical Engineering Design and Innovation II. Her research program is supported by various grants, though specific funding sources aren't detailed in the provided text. The Raimondo Research Lab represents a dynamic environment where engineering principles are applied to solve complex biological challenges in drug delivery and regenerative medicine. The Raimondo Research Lab at Brown University serves as a hub for innovation in RNA delivery and biomaterials design. The lab brings together expertise in chemical engineering, molecular biology, and immunology to develop next-generation therapeutic platforms. Current research directions include optimizing lipid nanoparticle formulations, exploring novel RNA modifications, and investigating immune responses to RNA therapeutics across various disease contexts.
Kristina Schoonjans is an Associate Professor at EPFL’s School of Life Sciences, where she leads the Laboratory of Metabolic Signaling (UPSCHOONJANS). Her research focuses on the molecular mechanisms of bile acid signaling, nutrient sensing, and intermediary metabolism, particularly in the context of metabolic disorders such as obesity, fatty liver disease, and cancer. She investigates how the liver-gut-brain axis integrates metabolic signals through nuclear receptors and mitochondrial dynamics. Her research interests include: Bile acid signaling and its role as a hormonal regulator Nutrient and metabolite sensing in energy homeostasis Intermediary metabolism and metabolic disorders Role of nuclear receptors (e.g., TGR5, LRH-1) in liver, gut, and adipose tissue Mitochondrial dynamics and fission in metabolic regulation Organoid models for studying liver and intestinal metabolism Systems genetics using BXD mouse populations The most recent articles highlight a strong focus on bile acid signaling, particularly through TGR5 and LRH-1, in regulating metabolic health. Themes include the conversion of white fat to beige fat (beiging), hepatic tumorigenesis, mitochondrial fission, and the use of organoid and genetically engineered mouse models. There is a consistent emphasis on translational applications for obesity, fatty liver disease, and cancer. Scientific honors include: Windaus Prize from the Dr. Falk Foundation (2010, shared with Johan Auwerx) for the discovery of the signaling/endocrine function of bile acids Prof. Schoonjans actively supervises PhD students and has advised numerous doctoral candidates who have since completed their theses. Her lab is supported by multiple grants from Swiss and international funding agencies, including the Swiss National Science Foundation, EPFL, CONACYT, and the Foundation for Health and Education. She teaches in several doctoral programs at EPFL, including Life Sciences Engineering, and contributes to education through the SSV and EDBB/EDCB/EDMS-ENS programs. The Schoonjans Lab brings together scientists, doctoral assistants, and technicians working on projects related to metabolic signaling. The team uses advanced techniques such as genetically modified mouse models, organoid cultures, and multi-omics (metabolomics, proteomics, transcriptomics) to study the liver-gut and brain-liver axes. The lab has a strong track record of high-impact publications and collaborations with institutions worldwide.
Stephen Parada is a Professor at the Medical College of Georgia, with academic appointments in the Department of Orthopedic Surgery. He is actively involved in clinical education and research, contributing significantly to orthopedic surgery, particularly in shoulder and elbow arthroplasty and biomechanics. Research Interests: His work spans orthopedic surgery, biomechanics, surgical outcomes, and the application of artificial intelligence in patient education. He focuses on improving clinical outcomes in total joint replacement, understanding shoulder instability, and evaluating publication trends in orthopedic research. The recent publications indicate a strong trend toward evidence-based orthopedics, with emphasis on predictive modeling of surgical outcomes, implant longevity, and the role of digital tools in patient communication. His research bridges clinical practice with academic scholarship. Scientific Awards: AAOS Kappa Delta Award, AAOS, 2025 Resident Research Award, Georgia Orthopaedic Society, 2022 GME Exemplary Teaching Award, Medical College of Georgia, 2021 GME Exemplary Teaching Award, Medical College of Georgia, 2020 Teaching and Service: Dr. Parada teaches key surgical clerkships and orthopedic externships. He serves on the AAOS Exhibits Committee and holds leadership roles in the Georgia Shoulder & Elbow Society. His professional service includes roles in ASES, AANA, and AAOS annual meetings, reflecting active engagement in national orthopedic communities. Laboratories and Research Teams: He is involved in Orthopaedic Research at the Medical College of Georgia (2023–present), contributing to a collaborative environment focused on advancing musculoskeletal care through innovation and education.
Gustavo Nader, Ph.D., is a Professor of Kinesiology at The Pennsylvania State University's College of Health and Human Development, where he holds the Dorothy Foehr Huck and J. Loyd Huck Endowed Chair in Molecular, Cellular and Integrative Physiology. His research laboratory at 101 Noll Lab focuses on molecular mechanisms of skeletal muscle adaptation, employing human, animal, and cellular models to investigate ribosome biogenesis, transcriptional regulation, and muscle growth control in contexts ranging from exercise hypertrophy to cancer cachexia. Dr. Nader's research examines fundamental processes including: Ribosome biogenesis and its role in muscle growth regulation Epigenetic control of RNA Polymerase I activity Molecular pathways in mechanical overload-induced hypertrophy Tumor-induced muscle wasting mechanisms Biomimicry approaches inspired by hibernator physiology His work spans exercise physiology, cancer biology, and environmental stress responses. Analysis of his 15 most recent publications (2015-2025) reveals predominant themes in muscle hypertrophy mechanisms, cancer cachexia pathophysiology, ribosomal function analysis, and environmental stress impacts on muscle. His work consistently integrates molecular techniques with physiological models across species. Notable scientific recognitions include: Dorothy Foehr Huck and J. Loyd Huck Chair appointment (2024) Huck Institutes Leadership Fellowship (2025-2026) Dr. Nader leads an active research team investigating muscle plasticity, with current projects funded through the Huck Institutes of the Life Sciences. He collaborates extensively through Penn State's Integrative and Biomedical Physiology graduate program and Center for Cellular Dynamics.
Xenophon Papademetris is a Professor of Biomedical Informatics & Data Science and Radiology & Biomedical Imaging at Yale School of Medicine. He serves as Associate Director of Biomedical Imaging Data Sciences at Yale Biomedical Imaging Institute and directs the Medical Software and Medical Artificial Intelligence Certificate Program. PhD in Electrical and Information Sciences from Yale University (2000) BA from Cambridge University (1994) Postdoctoral Fellowship at Yale University (2002) His research focuses on medical image analysis, machine learning, and biomedical software development. He has developed tools like BioImage Suite Web and contributed to standards committees at the Association for the Advancement of Medical Instrumentation (AAMI). His work spans modalities including MRI, CT, PET, and optical imaging. Recent publications emphasize neuroimaging analysis, explainable AI in healthcare, and multimodal data integration across species. He leads NIH-funded research under the BRAIN Initiative (R24 MH114805) and has authored a textbook on Medical Software published by Cambridge University Press. IEEE Senior Member Yale Brown-Coxe Postdoctoral Fellowship Harding Bliss Prize for Excellence in Engineering He directs the BioImage Suite Project, creating web-based image analysis tools using JavaScript and WebAssembly. His teaching includes both academic courses and a Coursera program on Medical Software with over 14,000 enrollments.
Professor Ingrid Undeland leads the Marine research group at the Division of Food and Nutrition Science, Department of Life Sciences at Chalmers University of Technology. She is a distinguished researcher with expertise spanning marine food science, lipid chemistry, and blue biorefining, having established herself as a leading figure in sustainable seafood research and marine biotechnology. Her educational background includes food science studies from Linnaeus University and a PhD in bioscience from Chalmers University of Technology and SIK (now RISE). Between 1999-2002, she was a post-doctoral fellow at University of Massachusetts Marine Station, which significantly shaped her research trajectory in marine food science. Professor Undeland's research focuses on pioneering next-generation seafood through innovative value chains from seaweed, small pelagic fish, fish side streams, mussels, and microalgae. Her specialized expertise lies in marine lipids and proteins, particularly their stabilization, isolation from complex sources, and nutritional properties including digestibility. She has extensive experience with antioxidant strategies using plant-derived side streams or extracts and fundamental studies of fish hemoglobins as pro-oxidants. Her work also encompasses innovative technologies for biomass fractionation and nutrient recycling to build blue biorefineries, along with in vitro digestion models and general seafood analytics. Beyond marine research, she explores filamentous fungi as sustainable alternative food protein sources. The trends in her recent publications reveal a strong emphasis on valorizing marine resources through advanced processing techniques. Her work increasingly focuses on sustainable extraction methods for seaweed proteins, particularly Ulva fenestrata, and developing antioxidant strategies using berry side streams to stabilize fish proteins. There's a growing interest in understanding the nutritional properties and digestibility of alternative marine proteins, along with environmental assessments of processing technologies. Her research consistently bridges fundamental science with practical applications for creating sustainable seafood value chains. Swedish representative in Nordic Lipidforum, WEFTA, and EuCheMS Editorial board member of Journal of the Aquatic Food Product Technology Member of the National Committee for Nutrition and Food Science at the Royal Swedish Academy of Sciences Co-founder of the startup company AquaFood H-index of 47 according to Google Scholar Professor Undeland has an extensive record of academic mentorship, having supervised or currently supervising 23 PhD students, 14 postdoctoral researchers, and examining over 25 MSc students. Her research is supported by numerous grants, including the WaSeaBi Project which focuses on valorizing seafood side-streams through holistic value chain design. She collaborates with various industry partners and academic institutions across Europe. Her laboratory includes technicians Dr. Karin Larsson and Dr. Rikard Fristedt, and she leads a dynamic research team working on multiple projects related to marine biorefining and sustainable seafood development. Her research group operates within well-equipped facilities at Chalmers University, with specialized laboratories for marine food analysis, protein extraction, lipid oxidation studies, and in vitro digestion modeling. The team also maintains cultivation systems for seaweed and filamentous fungi, enabling integrated research from raw material production to final product development.
Thomas Grenier is an Associate Professor in the Department of Electrical Engineering at INSA Lyon and a member of the CREATIS laboratory (CNRS UMR 5220, INSERM U1294). He obtained his HDR (Habilitation à Diriger des Recherches) in 2023 and his Ph.D. in Image Processing from INSA Lyon in 2005. His research focuses on medical image segmentation, clustering, and filtering using feature space, scale-space, and deep learning approaches. Doctoral School: EEA (Electronics, Energy, and Automatics) Research Affiliation: CREATIS Lab (CNRS/INSERM/INSA Lyon/Université Lyon 1/Université Jean Monnet Saint-Etienne) He has contributed to 20 papers and co-supervised 5 PhD students, including Léo Dumortier and Florent Guépin. Grenier leads the annual Deep Learning for Medical Imaging (DLMI) school, which he co-founded, and has organized five editions across Lyon and Montreal since 2019. The school emphasizes practical deep learning applications in medical imaging for participants of all expertise levels. His work spans interdisciplinary domains such as medical imaging , deep learning , and image processing , with recent publications on generative AI for MRI synthesis, explainable networks, and segmentation of neurological pathologies in preclinical models. He manages pedagogical platforms, coordinates LabEx PRIMES project activities, and oversees lab room infrastructure for 200 hours/year across 10 training programs. Grenier also leads the MUSIC transversal project on Multiple Sclerosis since 2019.
